Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE:DGX) with a Buy recommendation. Analyst Price Forecast Suggests 7.56% Upside As of March 19, 2025, ...

Redburn Atlantic analyst Jamie Clark initiated coverage of Quest Diagnostics (DGX) with a Buy rating and $195 price target Don't Miss Our End ...

Investment analysts at Leerink Partnrs dropped their Q2 2025 earnings per share (EPS) estimates for shares of Quest ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in ... See the top stocks recommended by analysts >> Quest Diagnostics (DGX) Truist Financial analyst David S ...

The analysis of recent analyst actions sheds light on the perception of Quest Diagnostics by financial experts. The following summary presents key analysts, their recent evaluations, and ...

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (NYSE ... and includes fundamentals, analyst reports, ownership data and fund sentiment, options ...

Fintel reports that on April 2, 2025, Redburn Atlantic initiated coverage of Quest Diagnostics (LSE ... and includes fundamentals, analyst reports, ownership data and fund sentiment, options ...